Recipient(s) will receive an email with a link to 'Iron (Fe)' and will have access to the topic for 7 days.
Subject: Iron (Fe)
(Optional message may have a maximum of 1000 characters.)
Iron exists in the body in many forms: hemoglobin in circulating red cells and developing erythroblasts, iron-containing proteins such as myoglobin and cytochromes, and bound to transferrin and storage in the form of ferritin and hemosiderin. Iron homeostasis is regulated strictly at the level of intestinal absorption and release of iron from macrophages. The serum iron level reflects Fe3+ bound to transferrin, not free Hb in serum.
Female: 28–170 μg/dL
Male: 45–182 μg/dL
Diagnosis of blood loss
Differential diagnosis of anemias
Diagnosis of hemochromatosis and hemosiderosis
Evaluation of iron deficiency; should always be measured with TIBC
Diagnosis of acute iron toxicity, especially in children
Evaluation of thalassemia and sideroblastic anemia
Monitor response to treatment for anemia
Hemosiderosis of excessive iron intake (e.g., repeated blood transfusions, iron therapy, iron-containing vitamins) (may be >300 μg/dL)
Decreased formation of RBCs (e.g., thalassemia, pyridoxine deficiency anemia, PA in relapse)
Increased destruction of RBCs (e.g., hemolytic anemias)
Acute liver damage (degree of increase parallels the amount of hepatic necrosis) (may be >1,000 μg/dL); some cases of chronic liver disease
Progesterone birth control pills (may be >200 μg/dL) and pregnancy
Premenstrual elevation by 10–30%
Acute iron toxicity; serum iron-to-TIBC ratio is not useful for this diagnosis
Vitamin B6 deficiency
Iron deficiency anemia
Normochromic (normocytic or microcytic) anemias of infection and chronic diseases (e.g., neoplasms, active collagen diseases)
Acute and chronic infection
Postoperative state and kwashiorkor
Nephrosis (because of loss of iron-binding protein in urine)
PA at onset of remission
Menstruation (decreased by 10–30%)
Serum iron is not reliable as the primary test to identify iron deficiency or screening for hemochromatosis and other iron overload diseases. For these conditions, a serum TIBC, percent transferrin saturation, and ferritin assay are recommended.
Diurnal variation—normal values in midmorning, low values in midafternoon, very low values (approximately 10 μg/dL) near midnight. Diurnal variation disappears at levels <45 μg/dL.
Iron dextran administration causes increase for several weeks (may be >1,000 μg/dL).
Ingestion of oral contraceptives will elevate iron and/or total iron-binding capacity values.
Not recommended for patients undergoing treatment with deferoxamine or other iron-chelating compounds.
Ingestion of iron (including iron-fortified vitamins or supplements) may cause transient elevated iron levels.